@article{beaufaller:hal-01064291,
TITLE = {A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platforms},
AUTHOR = {Beau-Faller, Mich{\`e}le and Blons, H{\'e}l{\`e}ne and Domerg, Caroline and Gajda, Dorota and Richard, Nicolas and Escande, Fabienne and Solassol, J{\'e}r{\^o}me and Denis, Marc G. and Cayre, Anne and Nanni-Metellus, Isabelle and Olschwang, Sylviane and Lizard, Sarab and Piard, Fabienne and Pretet, Jean-Luc and Fraipont, Florence De and Bi{\`e}che, Ivan and Cremoux, Patricia De and Rouquette, Isabelle and Bringuier, Pierre-Paul and Mosser, Jean and Legrain, Mich{\`e}le and Voegeli, Anne-Claire and Saulnier, Patrick and Morin, Franck and Pignon, Jean-Pierre and Zalcman, G{\'e}rard and Cadranel, Jacques},
URL = {https://hal.science/hal-01064291},
JOURNAL = {Journal of Molecular Diagnostics},
PUBLISHER = {American Society for Investigative Pathology (ASIP)},
VOLUME = {16},
NUMBER = {1},
PAGES = {45--55},
YEAR = {2014},
DOI = {10.1016/j.jmoldx.2013.07.009},
KEYWORDS = {Base Sequence ; Carcinoma ; Non-Small-Cell Lung ; Lung Neoplasms ; Molecular Diagnostic Techniques ; Nucleic Acid Amplification Techniques ; Adenocarcinoma ; High-Throughput Nucleotide Sequencing ; Genotype ; False Positive Reactions ; Tumor ; Cell Line ; Humans ; DNA ; Sequence Analysis ; Antineoplastic Agents ; Epidermal Growth Factor ; Receptor ; ras Proteins ; Quinazolines ; Proto-Oncogene Proteins ; Protein Kinase Inhibitors},
HAL_ID = {hal-01064291},
HAL_VERSION = {v1},
}